Skip to main content
. 2019 Jan 17;31(2):180–187. doi: 10.1016/j.joco.2018.12.006

Fig. 5.

Fig. 5

Safe tapering of therapy in a Vogt-Koyanagi-Harada disease (VKH) patient. CS: Corticosteroids, prednisone, ¼CS: Quarter dose of prednisone, CsA: Cyclosporine. MYF: Myfortic® 0 mycophenolic acid. REM: Remicade® REM = infliximab, anti-TNF-α agent. REM X 8 = Remicade every 8 weeks (5 mg/kg). Pink shadowed area shows that several treatment combinations were necessary until disease was under control. MYF: Myfortic, REM: Remicade, CsA: Ciclosporine, P: Prednisone, ttt: Treatment.